Table 2 Measurement methods used in the literatures

psychosocial

Quality of life

Dermatology Life Quality Index (DLQI) (N = 32)

European Quality of Life-5 Dimensions (EQ-5D) (N = 7)

Short Form Health Survey (SF-36) (N = 2)

General Health Questionnaire (GHQ) (N = 1)

World Health Organization Quality of Life-BREF (N = 1)

Short form of the General Health Questionnaire (GHQ-28) (N = 1)

Short-Form 12 health status instrument (N = 1)

Eczema Quality of Life Scale (EQOLS) (N = 1)

Revised Dyadic Adjustment Scale (R-DAS) (N = 1)

Subjective Burden

Skindex-29 (N = 2)

Skindex-16 (N = 2)

Skindex-19 (N = 1)

psychological

Anxiety and depression

Hospital Anxiety and Depression Scale (HADS) (N = 13)

Beck Depression Inventory (BDI) (N = 8)

42-item Depression, Anxiety and Stress Scale (DASS-42) (N = 2)

Social Anxiety Questionnaire (SAQ) (N = 2)

Center for Epidemiologic Studies Depression Scale (CES-D) (N = 2)

Self-Rating Depression Scale (SDS)&Self-Rating Anxiety (SAS) (N = 1)

Patient Health Questionnaire Depression Scale (PHQ-9) (N = 1)

Generalized Anxiety Disorder Scale (GAD-7) (N = 1)

Arabic version of the Depression, Anxiety and Stress Scale (N = 1)

Penn State Worry Questionnaire (N = 1)

State-Trait-Anxiety Inventory (N = 1)

Body image

Body Emotions Scale (BES) (N = 2)

Appearance Schemas Inventory-Revised (ASI-R) (N = 2)

Body Image Scale (BIS) (N = 2)

Body Dysmorphic Disorder Questionnaire (BDDQ) (N = 1)

Female Genital Self-image Score (FGSIS) (N = 1)

Acceptance of Life with the Disease Scale (ALDS) (N = 1)

Perceived Health Status (PHS) (N = 1)

Multidimensional Body-Self Relations Questionnaire (MBSRQ) (N = 1)

Skin Satisfaction Questionnaire (SSQ) (N = 1)

Derriford Appearance Scale (DAS-24) (N = 1)

Self-esteem

Rosenberg Self-esteem Scale (RSES) (N = 5)

Fears of Compassion Scales (FCS) (N = 1)

Brief Fear of Negative Evaluation Scale (Brief FNE) (N = 1)

Stigmatization

Stigmatization Scale (N = 3)

Stigmatization and Psoriasis Questionnaire (SPQ) (N = 1)

Psoriasis disease stigma questionnaire (PSQ) (N = 1)

Internalized Stigma Scale (ISS) (N = 1)

Alexithymia

Toronto Alexithymia Scale (TAS) (N = 1)

social

Social support

Berlin Social Support Scales (BSSS) (N = 1)

Social support rating scale (SSS) (N = 1)

Disease-Related Social Support Scale (DRSS) (N = 1)

Multidimensional Scale of Perceived Social Support (MSPSS) (N = 1)

Social interaction

Social Readjustment Rating Scale (N = 1)

Participation Scale Questionnaire (N = 1)

Social acceptance

Marlowe–Crowne Social Desirability Scale (MC-SDS) (N = 1)

Occupational effect

Work Productivity and Activity Impairment (WPAI) (N = 4)

Work Productivity and Activity Impairment Questionnaire: Psoriasis (WPAI-PSO) (N = 1)

Work Productivity and Activity Impairment-General Health (WPAI-GH) (N = 1)

Work Limitation Questionnaire (WLQ) (N = 1)

Total work productivity impairment (TWPI) (N = 1)

Total activity impairment (TAI) (N = 1)

Economic burden

Direct costs (N = 1)

Direct Costs of AD: medications, over-the-counter costs, medical testing and procedure expenses, physician visits, out-of-pocket expenses, transportation, and childcare increased as severity of AD worsened (N = 1)

Indirect Costs of AD (productivity loss of caregivers) (N = 1)

Lost productivity (N = 1)

Physical

Disease severity

Psoriasis Area and Severity Index (PASI) (N = 16)

Psoriasis Disability Index (PDI) (N = 3)

Vitiligo area scoring index (VASI) (N = 1)

Distress Thermometer (DT) (N = 1)

Physician global assessment (PGA) (N = 1)

Severity scoring of AD (SCORAD) (N = 1)

Physicians Global Assessment (PGA) score (N = 1)

Hand eczema severity:10-point visual analogue scale (VAS) (N = 1)

Patient-Oriented Scoring Atopic Dermatitis (PO-SCORAD) index (N = 1)

Impact of chronic Skin Disease on Daily Life (ISDL) (N = 1)

Self-Administered Psoriasis Area and Severity Index (SAPASI) (N = 1)

Clinical feature

Itching/pruritus: Visual Analogue Scale (VAS) (N = 2)

Juckreiz-Kognitions-Fragebogen questionnaire (N = 1)

SCORAD index (N = 1)

Distribution and extent

Body Surface Area (BSA) (N = 6)

Body surface involvement (N = 1)

Others

Sexual life

Massachusetts General Hospital-Sexual Functioning Questionnaire (MGH-SFQ) (N = 2)

Female Sexual Function Index (FSFI) (N = 1)

International Index of Erectile Function (IIEF) (N = 1)

Stress

Psoriasis Life Stress Inventory (PLSI) (N = 1)

Stress Self-assessment Scale (N = 1)

Personality

Eysenck Personality Questionnaire (EPQ) (N = 1)

Eysenck Personality Inventory (N = 1)

Life course

Course of life questionnaire (COLQ) (N = 1)

Modified psoriasis life stress inventory (N = 1)

Loneliness

UCLA loneliness scale (UCLA-Version 3) (N = 1)

Sleep Quality

Medical Outcomes Study Sleep Scale (MOS-SS) (N = 1)

Disease control

Urticaria Control Test (UCT) (N = 1)

Knowledge

Psoriasis Knowledge Assessment Questionnaire (N = 1)

Biological Markers

CRP and cytokines IL-1β, IL-6, TNFα, and IL-17 (N = 1)

Mindfulness

Five Facet Mindfulness Questionnaire (N = 1)